{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:09:03Z","timestamp":1756382943904},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T00:00:00Z","timestamp":1206489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s12185-008-0064-9","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T05:33:06Z","timestamp":1206423186000},"page":"440-441","source":"Crossref","is-referenced-by-count":1,"title":["Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia\/hypereosinophilic syndrome with FIP1L1-PDGFR\u03b1 fusion gene"],"prefix":"10.1007","volume":"87","author":[{"given":"Keisuke","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumimasa","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hangaishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Motokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,26]]},"reference":[{"key":"64_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00062752-200701000-00008","volume":"14","author":"S Fletcher","year":"2007","unstructured":"Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol. 2007;14:37\u201342.","journal-title":"Curr Opin Hematol"},{"key":"64_CR2","first-page":"29","volume-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"B Bain","year":"2001","unstructured":"Bain B, Vardiman JW, Pierre R, Brunning RD, Imbert M, Flandrin G. Chronic eosinophilic leukemia and the hypereosinophilic syndrome. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 29\u201331."},{"key":"64_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, De Angelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201\u201314.","journal-title":"N Engl J Med"},{"key":"64_CR4","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1182\/blood.V78.10.2626.2626","volume":"78","author":"L Prin","year":"1991","unstructured":"Prin L, Plumas J, Gruart V, et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood. 1991;78:2626\u201332.","journal-title":"Blood"},{"key":"64_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ajcp\/92.2.186","volume":"92","author":"M Chilosi","year":"1989","unstructured":"Chilosi M, Semenzato G, Vinante F, et al. Increased levels of soluble interleukin-2 receptor in non-Hodgkin\u2019s lymphoma: relationship with clinical, histologic, and phenotypic features. Am J Clin Pathol. 1989;92:186\u201391.","journal-title":"Am J Clin Pathol"},{"key":"64_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1532\/IJH97.06047","volume":"85","author":"K Miyazawa","year":"2007","unstructured":"Miyazawa K, Kakazu N, Ohyashiki K. Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid. Int J Hematol. 2007;85:5\u201310.","journal-title":"Int J Hematol"},{"key":"64_CR7","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","volume":"109","author":"JV Jovanovic","year":"2007","unstructured":"Jovanovic JV, Score J, Waghorn K, et al. Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood. 2007;109:4635\u201340.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0064-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0064-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T10:00:54Z","timestamp":1588500054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0064-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,26]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0064-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,26]]}}}